Global Molecular Scissors Technology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Molecular Scissors Technology Market Research Report 2024
Molecular scissors technology is a tool for cutting long chains of DNA molecules. Its essence is a restriction enzyme. They can find a specific "cutting point" on DNA, and cut the double strands of DNA molecules staggered after recognition.
According to MRAResearch’s new survey, global Molecular Scissors Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Scissors Technology market research.
In 1968, Dr. Werner Albert, Dr. Daniel Nathans, and Dr. Hamilton Smith first extracted restriction enzymes from E. coli. They were able to find specific "cut points" on DNA , And cut the double-stranded DNA molecules in a staggered manner. People call this restriction enzyme "molecular scissors". This "molecular scissors" can cut off individual genes completely. Since the 1970s, more than 400 "molecular scissors" have been isolated and extracted, and many of these "molecular scissors" have been identified. With all kinds of "molecular scissors", people can cut long chains of DNA molecules at will. Due to the discovery of restriction enzymes, Albert, Smith and Nathans shared the 1978 Nobel Prize in Physiology and Medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Molecular Scissors Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cibus
Thermo Fisher Scientific, Inc.
Merck
Recombinetics
Sangamo Therapeutics
Editas Medicine
Precision BioSciences
Intellia Therapeutics, Inc.
Caribou Biosciences, Inc
Cellectis
Segment by Type
Cas9
TALENs and MegaTALs
ZFN
Others
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Molecular Scissors Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Molecular Scissors Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Scissors Technology market research.
In 1968, Dr. Werner Albert, Dr. Daniel Nathans, and Dr. Hamilton Smith first extracted restriction enzymes from E. coli. They were able to find specific "cut points" on DNA , And cut the double-stranded DNA molecules in a staggered manner. People call this restriction enzyme "molecular scissors". This "molecular scissors" can cut off individual genes completely. Since the 1970s, more than 400 "molecular scissors" have been isolated and extracted, and many of these "molecular scissors" have been identified. With all kinds of "molecular scissors", people can cut long chains of DNA molecules at will. Due to the discovery of restriction enzymes, Albert, Smith and Nathans shared the 1978 Nobel Prize in Physiology and Medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Molecular Scissors Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cibus
Thermo Fisher Scientific, Inc.
Merck
Recombinetics
Sangamo Therapeutics
Editas Medicine
Precision BioSciences
Intellia Therapeutics, Inc.
Caribou Biosciences, Inc
Cellectis
Segment by Type
Cas9
TALENs and MegaTALs
ZFN
Others
Segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Molecular Scissors Technology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source